Pfizer Begins First Dosing for COVID-19 Vaccine Program
by Press Release from Outbreak News Today on (#53382)
Pfizer Inc. and BioNTech SE announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase [...]
The post Pfizer Begins First Dosing for COVID-19 Vaccine Program appeared first on Outbreak News Today.